Insider Trading March 3, 2026

Amwell International Head Sells $18,722 in Stock to Cover RSU Taxes

Phyllis Gotlib executed an automatic 'sell to cover' on March 2, 2026; company reports revenue pressures but ends year with cash and no debt

By Jordan Park AMWL
Amwell International Head Sells $18,722 in Stock to Cover RSU Taxes
AMWL

Phyllis Gotlib, President, International at American Well Corp (AMWL), sold 3,573 shares of Class A common stock on March 2, 2026, in an automatic transaction to meet tax obligations tied to restricted stock units that vested on March 1, 2026. The sale totaled $18,722 at $5.24 per share. The move comes as AMWL shares trade at $5.15, down 41% over the past year, even as the stock has posted gains in the most recent three-month period. Separately, the company reported a 22.1% year-over-year revenue decline in Q4 2025 but finished the year with $182 million in cash and no debt.

Key Points

  • Insider transaction: Phyllis Gotlib sold 3,573 Class A shares on March 2, 2026 at $5.24 per share, generating $18,722 to cover RSU-related taxes.
  • Shareholding and price context: After the sale Gotlib holds 116,297 shares; AMWL was trading at $5.15, down 41% year-over-year but up over the past three months.
  • Financial snapshot: Amwell reported a 22.1% year-over-year revenue decline in Q4 2025 yet finished the year with $182 million in cash and no debt; technology and AI integration cited as factors shaping investor sentiment.

Phyllis Gotlib, who serves as President, International for American Well Corp (NASDAQ: AMWL), sold 3,573 shares of the company's Class A common stock on March 2, 2026. The shares were disposed of at a price of $5.24 each, producing proceeds of $18,722.

At the time of the transaction, AMWL shares were trading at $5.15. Over the trailing 12 months the stock has fallen 41%, although it has shown a degree of momentum in the more recent three-month window.

Following the sale, Gotlib retains direct ownership of 116,297 shares of American Well Corp. Company filings indicate the disposition was executed through an automatic "sell to cover" arrangement designed to meet the tax liability associated with the vesting and settlement of restricted stock units (RSUs) that occurred on March 1, 2026.

Information cited in filings and related summaries notes that, despite ongoing profitability challenges, the company’s balance sheet shows more cash than debt. That observation is paired with a specific figure: Amwell closed the year with $182 million in cash and reported no debt on the books.

On the revenue side, Amwell disclosed a marked downturn in its fourth quarter of 2025 results. Revenue for Q4 2025 declined 22.1% compared with the same quarter a year earlier. Management commentary and market summaries have pointed to efforts around technology and AI integration as elements that may have contributed to recent investor interest, even as the company navigates a difficult operating year.

These items - the insider sale to meet RSU-related taxes, the stock’s recent price action, the year-over-year revenue drop, and the year-end cash and debt position - form the latest public details on Amwell’s financial condition and strategic trajectory.

Risks

  • Ongoing profitability challenges explicitly noted in company summaries - impacts operating performance and investor confidence, particularly in the healthcare technology and telehealth sectors.
  • A significant revenue decline - Q4 2025 revenue fell 22.1% year-over-year, indicating potential headwinds for top-line recovery in the near term.
  • Share price volatility - the stock has declined 41% over 12 months, creating market risk for equity holders and potential implications for capital-raising strategies.

More from Insider Trading

DraftKings CFO Sells Small Block as Company Faces Mixed Signals from Analysts Mar 3, 2026 Barrett Business Services Director Mark Steven Finn Adds $55K in Stock Mar 3, 2026 Chevron New Energies President Disposes of $1.24 Million in CVX Shares; Options Exercise Also Recorded Mar 3, 2026 Krystal Biotech Director Sells $3.25 Million in Stock; Company Posts Q4 2025 Beat Mar 3, 2026 Docusign Director Sells Small Stake as Company Rolls Out AI Contract Tools Mar 3, 2026